Lineage Cell Therapeutics In shares owned by Citigroup
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $38k | 26k | 1.48 |
| 2023-12-31 | $26k | 24k | 1.09 |
| 2023-09-30 | $157k | 133k | 1.18 |
| 2023-03-31 | $694k | 463k | 1.50 |
| 2022-12-31 | $558k | 477k | 1.17 |
| 2022-09-30 | $154k | 136k | 1.13 |
| 2021-12-31 | $87k | 36k | 2.44 |
| 2021-03-31 | $19k | 8.1k | 2.34 |
| 2020-12-31 | $10k | 5.9k | 1.70 |
| 2020-09-30 | $6.0k | 5.9k | 1.02 |
| 2020-06-30 | $5.0k | 5.9k | 0.85 |
| 2020-03-31 | $31k | 37k | 0.84 |
| 2019-12-31 | $30k | 34k | 0.88 |
| 2019-09-30 | $15k | 16k | 0.96 |